Society guideline links: Melanoma screening, prevention, diagnosis, and management

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of melanoma – Version 3.0, update (2023)

Canada

●Cancer Care Ontario (CCO): Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma (2024)

●CCO: Surveillance of patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent (2023)

●CCO: Locoregional management of in-transit metastasis in melanoma (2020)

●CCO: Surgical management of patients with lymph node metastases from cutaneous melanoma of the trunk or extremities (2018)

●CCO: Primary excision margins and sentinel lymph node biopsy in cutaneous melanoma (2017)

●CCO: The use of adjuvant radiation therapy for curatively resected cutaneous melanoma (2016)

●CCO: A systematic review and clinical practice guideline on the use of indoor tanning devices and the risk of developing cutaneous malignant melanoma (2014)

●CCO: PET imaging in melanoma (2009)

United States

●National Cancer Institute (NCI): Skin cancer (including melanoma) – Health professional version

●American Society of Clinical Oncology (ASCO): Guideline on systemic therapy for melanoma, update (2023)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on screening for skin cancer (2023)

●American Academy of Dermatology (AAD): Guidelines of care for the management of primary cutaneous melanoma (2019)

●USPSTF: Final recommendation statement on skin cancer prevention – Behavioral counseling (2018)

Europe

●European Association of Dermato-Oncology (EADO), European Dermatology Forum (EDF), and European Organization for Research and Treatment of Cancer (EORTC): European consensus-based interdisciplinary guideline for melanoma – Part 1: Diagnostics, 2024 update (published 2025)

●EADO, EDF, and EORTC: European consensus-based interdisciplinary guideline for melanoma – Part 2: Treatment, 2024 update (published 2025)

●European Society for Medical Oncology (ESMO): Clinical practice guideline for diagnosis, treatment, and follow-up of cutaneous melanoma (2025)

●European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT)/Paediatric Rare Tumours Network - European Registry (PARTNER): Diagnostic and therapeutic recommendations on cutaneous melanoma in children and adolescents (2021)

●European Society of Pathology (ESP), EORTC, and European Rare Adult Cancer Network (EURACAN): Expert opinion – Practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variants (2021)

●ESMO: Consensus conference recommendations on the management of locoregional melanoma (2020)

●ESMO: Consensus conference recommendations on the management of metastatic melanoma (2020)

●European Association of Nuclear Medicine (EANM): Practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma (2015)

United Kingdom

●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on cutaneous melanoma (2017, revised 2023)

●National Institute for Health and Care Excellence (NICE): Guideline on melanoma – Assessment and management (2015, updated 2022)

●NICE: Quality standard on skin cancer (2016, updated 2022)

●United Kingdom national guidelines on ano-uro-genital mucosal melanoma (2020)

●United Kingdom national guidelines on head and neck mucosal melanoma (2020)

●NICE: Public health guideline on skin cancer prevention (2011, updated 2016)

Australia–New Zealand

●Cancer Council Australia (CCA): Clinical practice guidelines for the diagnosis and management of melanoma (2024)

●Royal Australian College of General Practitioners (RACGP): Guidelines for preventive activities in general practice – Skin cancer, 10th edition (2024)

●CCA: Evidence-based clinical practice guidelines for management of melanoma brain metastases (2021)

●Royal College of Pathologists of Australasia (RCPA): Primary cutaneous melanoma structured reporting protocol, 2nd edition (2014)

Japan

●[In English] Japanese Dermatological Association (JDA): Guidelines – Outlines of guidelines for cutaneous melanoma, 2019 (published 2020)

●[In Japanese] JDA: Melanoma practice guidelines – Skin malignant tumor guideline, 3rd edition (2019)

●[In Japanese] Japanese Society for Dermatological Malignancies: Guide to drug therapy for malignant melanoma (2019)